Amarin Change in Accounts Payable 2010-2025 | AMRN

Amarin change in accounts payable from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

Amarin Change in Accounts Payable 2010-2025 | AMRN

Amarin change in accounts payable from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$243.4B
Amgen (AMGN)$156.3B
Gilead Sciences (GILD)$147.7B
Vertex Pharmaceuticals (VRTX)$100.1B
Bristol Myers Squibb (BMY)$97.3B
CSL (CSLLY)$85B
GSK (GSK)$80B
Regeneron Pharmaceuticals (REGN)$60B
Alnylam Pharmaceuticals (ALNY)$58B
Argenex SE (ARGX)$39.9B
BioNTech SE (BNTX)$27.1B
Insmed (INSM)$27B
Royalty Pharma (RPRX)$20.5B
Biogen (BIIB)$19.8B
Incyte (INCY)$16.8B
Illumina (ILMN)$15.4B
Genmab (GMAB)$14.7B
Genmab (GNMSF)$14.3B
Ascendis Pharma (ASND)$11.7B
BioMarin Pharmaceutical (BMRN)$11.1B
QIAGEN (QGEN)$10.9B
Moderna (MRNA)$10.4B
Exelixis (EXEL)$10.4B
Swedish Orphan Biovitrum (BIOVF)$10.3B
Verona Pharma American Depositary Share (VRNA)$9B
Exact Sciences (EXAS)$8.5B
Bio-Techne Corp (TECH)$8.4B
Blueprint Medicines (BPMC)$8.3B
Roivant Sciences (ROIV)$8B
Halozyme Therapeutics (HALO)$7.7B